Dr. Reddy's Laboratories Limited — Important, 22-07-2025: General Updates

Dr. Reddy's announced a key update concerning its USFDA inspection at the Middleburgh, New York API facility. The USFDA has classified the inspection outcome as 'Voluntary Action Indicated (VAI)', indicating no major issues requiring further action. The inspection is now officially closed. This is a highly positive operational development, effectively removing a regulatory overhang and ensuring continued smooth operations at this critical API manufacturing plant. It signals robust compliance and operational stability, which is favorable for business continuity and overall investor sentiment.